Relation Between Hospital Intra-Aortic Balloon Counterpulsation Volume and Mortality in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Background—Increasing evidence suggests an inverse relationship between outcome and the total number of invasive cardiac procedures performed at a given hospital. The purpose of the present study was to determine if a similar relationship exists between the number of intra-aortic balloon counterpulsation (IABP) procedures performed at a given hospital per year and the in-hospital mortality rate of patients with acute myocardial infarction complicated by cardiogenic shock. Methods and Results—We analyzed data of 12 730 patients at 750 hospitals enrolled in the National Registry of Myocardial Infarction 2 from 1994 to 1998. The hospitals were divided into tertiles (low–, intermediate–, and high–IABP volume hospitals) according to the number of IABPs performed at the given hospital per year. The median number of IABPs performed per hospital per year was 3.4, 12.7, and 37.4 IABPs at low-, intermediate-, and high-volume hospitals, respectively. Of those patients who underwent IABP, there were only minor differences in baseline patient characteristics between the 3 groups. Crude mortality rate decreased with increasing IABP volume: 65.4%, lowest volume tertile; 54.1%, intermediate volume tertile; and 50.6%, highest volume tertile (P for trend <0.001). This mortality difference represented 150 fewer deaths per 1000 patients treated at the high IABP hospitals. In the multivariate analysis, high hospital IABP volume for patients with acute myocardial infarction was associated with lower mortality (OR=0.71, 95% CI=0.56 to 0.90), independent of baseline patient characteristics, hospital factors, treatment, and procedures such as PTCA. Conclusions—Among the myocardial infarction patients with cardiogenic shock who underwent IABP placement, mortality rate was significantly lower at high–IABP volume hospitals compared with low–IABP volume hospitals.

[1]  H. White,et al.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.

[2]  S D Moulopoulos,et al.  Counterpulsation: historical background, technical improvements, hemodynamic and metabolic effects. , 1994, Cardiology.

[3]  A. Jacobs,et al.  Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction : A report from the shock trial Registry , 2000 .

[4]  F. Ragmin Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999, The Lancet.

[5]  V. Ho,et al.  Evolution of the volume-outcome relation for hospitals performing coronary angioplasty. , 2000, Circulation.

[6]  M. Gotsman,et al.  Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. , 1993, European heart journal.

[7]  R. Califf,et al.  Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase Results from GUSTO-III , 1999 .

[8]  L. Wallentin,et al.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999 .

[9]  J. Rumsfeld,et al.  Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. , 2000, JAMA.

[10]  J. Gore,et al.  The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. , 2001, American heart journal.

[11]  R. Califf,et al.  Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. , 1997, Journal of the American College of Cardiology.

[12]  E. Ohman,et al.  Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. , 1997, Journal of the American College of Cardiology.

[13]  S. Ayres,et al.  The effects of intra-aortic counterpulsation on cardiac performance and metabolism in shock associated with acute myocardial infarction. , 1971, The Journal of clinical investigation.

[14]  N. Every,et al.  A comparison of the national registry of myocardial infarction 2 with the cooperative cardiovascular project. , 1999, Journal of the American College of Cardiology.

[15]  M. Hlatky,et al.  Operator volume and clinical outcomes of primary coronary angioplasty for patients with acute myocardial infarction. , 2001, Circulation.

[16]  E. Braunwald,et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.

[17]  H. White,et al.  One-year survival following early revascularization for cardiogenic shock. , 2001, JAMA.

[18]  E. Ohman,et al.  The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. , 2001, Journal of the American College of Cardiology.

[19]  D. Pryor,et al.  The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality. , 1994, The New England journal of medicine.

[20]  J. Wilson,et al.  Volume and outcome of coronary artery bypass graft surgery. , 1987, JAMA.

[21]  K A Eagle,et al.  ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coro , 2001, Journal of the American College of Cardiology.

[22]  R. Califf,et al.  Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries. , 1999, European heart journal.

[23]  T. Ryan,et al.  Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. , 2000, JAMA.

[24]  E. Hannan,et al.  Investigation of the relationship between volume and mortality for surgical procedures performed in New York State hospitals. , 1990, JAMA.

[25]  T. Lörch,et al.  High resolution multicolor-banding: a new technique for refined FISH analysis of human chromosomes , 1999, Cytogenetic and Genome Research.

[26]  J. Gurwitz,et al.  Temporal trends in cardiogenic shock complicating acute myocardial infarction. , 1999, The New England journal of medicine.

[27]  David O. Williams,et al.  ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary , 2001 .

[28]  R. Becker,et al.  Hemodynamic, mechanical, and metabolic determinants of thrombolytic efficacy: a theoretic framework for assessing the limitations of thrombolysis in patients with cardiogenic shock. , 1993, American heart journal.

[29]  W. Rogers,et al.  The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. , 2000, The New England journal of medicine.

[30]  H. White,et al.  Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? , 2000, Journal of the American College of Cardiology.

[31]  R. Califf,et al.  Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. , 1997, Circulation.

[32]  P. Goldenheim Inactivation of HIV by povidone-iodine. , 1987, JAMA.

[33]  R. Califf,et al.  1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[34]  David M Williams,et al.  Pulmonary artery catheterization and clinical outcomes: National Heart, Lung, and Blood Institute and Food and Drug Administration Workshop Report. Consensus Statement. , 2000, JAMA.

[35]  R. Califf,et al.  One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial. , 1999, Circulation.